Townsquare Capital LLC Sells 324 Shares of Humana Inc. (NYSE:HUM)

Townsquare Capital LLC trimmed its holdings in shares of Humana Inc. (NYSE:HUM) by 2.3% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 13,841 shares of the insurance provider’s stock after selling 324 shares during the period. Townsquare Capital LLC’s holdings in Humana were worth $4,384,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. CarsonAllaria Wealth Management Ltd. boosted its stake in Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Creative Financial Designs Inc. ADV boosted its position in shares of Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares in the last quarter. Atwood & Palmer Inc. acquired a new stake in shares of Humana in the 3rd quarter valued at about $29,000. Hantz Financial Services Inc. bought a new stake in Humana in the 2nd quarter valued at about $35,000. Finally, Family Firm Inc. acquired a new position in Humana during the 2nd quarter worth approximately $37,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Up 0.4 %

NYSE:HUM opened at $296.68 on Friday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $526.47. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The firm’s 50 day moving average is $275.60 and its 200 day moving average is $329.77. The stock has a market capitalization of $35.72 billion, a PE ratio of 26.28, a price-to-earnings-growth ratio of 2.40 and a beta of 0.52.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Sell-side analysts expect that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a yield of 1.19%. Humana’s dividend payout ratio is presently 31.36%.

Analysts Set New Price Targets

HUM has been the subject of several recent research reports. Sanford C. Bernstein upgraded Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective for the company in a report on Tuesday, October 8th. JPMorgan Chase & Co. boosted their price target on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. UBS Group dropped their price objective on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Wells Fargo & Company decreased their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Finally, Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and raised their price target for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Twenty investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, Humana has a consensus rating of “Hold” and an average price target of $315.86.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.